
30 Jul 2025
From growth to (hopefully) value

Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
From growth to (hopefully) value
Novo Nordisk A/S Class B (NOVO.B:CSE) | 0 0 0.0%
- Published:
30 Jul 2025 -
Author:
ABGSC Healthcare Research | Morten Larsen -
Pages:
12 -